Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Helix BioPharma Corp. (T.HBP) had Stock-Based Compensation of 0.13M for the most recently reported fiscal quarter, ending 2025-07-31.
| Income Statement Financials | |
-- |
|
-0.67M |
|
-- |
|
-- |
|
-- |
|
-0.67M |
|
-- |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
-0.67M |
|
55.74M |
|
55.74M |
|
0.00 |
|
0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.23M |
|
-- |
|
-- |
|
-- |
|
2.26M |
|
10.96M |
|
-1.97M |
|
10.96M |
|
74.16M |
|
| Cash Flow Statement Financials | |
-2.70M |
|
0.01M |
|
1.97M |
|
0.76M |
|
0.05M |
|
-0.71M |
|
|
Stock-Based Compensation |
0.13M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.10% |
|
33.89% |
|
-5.05% |
|
-5.97% |
|
0.21 |
|
-0.05 |
|
-0.05 |
|